- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Hypertension and Dyslipidemia
Total 406806 results
-
GlaxoSmithKlineCompletedDyslipidaemia | DyslipidaemiasGermany, Estonia, Belgium, France, Netherlands, Denmark, Portugal, Norway, Sweden, Lithuania, Finland
-
GlaxoSmithKlineCompletedHealthy Subjects | Dyslipidaemia | DyslipidaemiasUnited Kingdom
-
Xention LtdCompleted
-
AstraZenecaCompletedDyslipidaemiaCzech Republic
-
AstraZenecaCompleted
-
Novartis PharmaceuticalsCompletedDyslipidaemiaJordan, United States, Taiwan
-
Boryung Pharmaceutical Co., LtdCompleted
-
Boryung Pharmaceutical Co., LtdCompletedEssential Hypertension, DyslipidemiaKorea, Republic of
-
GlaxoSmithKlineCompletedDyslipidemias | DyslipidaemiasUnited States
-
GlaxoSmithKlineCompletedDyslipidaemiasUnited States, Canada
-
Daewoong Pharmaceutical Co. LTD.UnknownHypertension, DyslipidemiaKorea, Republic of
-
GlaxoSmithKlineCompleted
-
Novo Nordisk A/SRecruitingHealthy Volunteers | DyslipidaemiaUnited States
-
AstraZenecaCompletedDyslipidaemiaRussian Federation
-
AstraZenecaCompletedHypercholesterolemia | Dyslipidaemia
-
Jeil Pharmaceutical Co., Ltd.CompletedDyslipidemia With HypertensionKorea, Republic of
-
IlDong Pharmaceutical Co LtdNot yet recruitingHypertension, Dyslipidemia
-
AstraZenecaCompletedHypercholesterolemia | Dyslipidaemia
-
Boryung Pharmaceutical Co., LtdCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemia Patients With HypertensionKorea, Republic of
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Daewon Pharmaceutical Co., Ltd.Completed
-
AstraZenecaCompletedDyslipidaemiaRussian Federation
-
Xention LtdCompleted
-
AstraZenecaCompletedHypercholesterolemia | Dyslipidaemia
-
Chong Kun Dang PharmaceuticalCompletedHypertensive Patients With DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
GlaxoSmithKlineCompletedHealthy Subjects | DyslipidaemiasUnited States
-
Yuhan CorporationCompletedDyslipidemia & HypertensionKorea, Republic of
-
GlaxoSmithKlineCompletedHealthy Subjects | DyslipidaemiasUnited States
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Jeil Pharmaceutical Co., Ltd.CompletedHypertension With DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Jeil Pharmaceutical Co., Ltd.CompletedHypertension With DyslipidemiaKorea, Republic of
-
AstraZenecaCompletedFredrickson Type IIa & Type IIb Dyslipidaemia
-
NeuroBo Pharmaceuticals Inc.CompletedSevere Hypertriglyceridemia | Mixed DyslipidaemiaUnited States, Canada
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHypertension | DyslipidemiaUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed